[…] structure of the DUX4 protein, which is responsible for the disease, facioscapulohumeral muscular dystrophy ( FSHD). Unlike the majority of genetic diseases, FSHD is not caused by a protein that […]
DUX4 structure unveiled
$447,620 in funding for four new projects
The FSHD Society Board of Directors approved $447,620 in funding for four projects submitted in the February 2019 cycle. These grants will move forward four distinct strategies that show promise. […]
Losmapimod as potential COVID-19 treatment?
[…] disease. Now we have learned that losmapimod, currently in a Phase 2b clinical trial for FSHD, will be investigated as a treatment for COVID-19. According to a press release issued […]
MRI in FSH muscular dystrophy research
This month’s FSHD University webinar (video above) provided an outstanding, nontechnical explanation of magnetic resonance technology (MRI) and how it is being applied in the Fulcrum Therapeutics clinical trial […]
St. Louis Chapter
[…] to the St. Louis Chapter! Thank you for visiting the St. Louis Chapter of the FSHD Society! We are here to build a local community of patients, family and friends, […]